Saturday, June 10, 2023 9:20:13 PM
Judge Smails 40,
If I was a chart guy I’d be looking at the left side of the chart and ask why the right side isn’t a mirror image. If you look up until 2020 it looks pretty symmetric right? So what happened?; ). I think plans changed to start looking at a bigger picture that was going to take more time to prepare for. Seems to be just after data lock and Flaskworks at the time that NWBO would have been given the data that the chart started shifting first sideways then down. Somebody seemed to understand that more time might be needed but the amount of time seemed uncertain so the drift then gradual down slope to the lowest and slowest uptrend which was rushed there by May 10th last year. Was tissue agnostic designation being discussed with regulators back in 2020-2021?; ).
The correction back up should take the chart up to $11 and beyond fairly quickly because the delay for everyone to get on board very likely has not been in vain but in preparation. NWBO is talking like DCVax is for more than just brain tumors. Have regulators been saying the same thing?; ). Did regulators want the bigger boat because they could see where the demand would be coming from and didn’t want to get caught in the middle of a stampede?; ). I don’t think Dr. Linda Liau just skips town for no reason when something important is about to be shared. Best wishes.
If I was a chart guy I’d be looking at the left side of the chart and ask why the right side isn’t a mirror image. If you look up until 2020 it looks pretty symmetric right? So what happened?; ). I think plans changed to start looking at a bigger picture that was going to take more time to prepare for. Seems to be just after data lock and Flaskworks at the time that NWBO would have been given the data that the chart started shifting first sideways then down. Somebody seemed to understand that more time might be needed but the amount of time seemed uncertain so the drift then gradual down slope to the lowest and slowest uptrend which was rushed there by May 10th last year. Was tissue agnostic designation being discussed with regulators back in 2020-2021?; ).
The correction back up should take the chart up to $11 and beyond fairly quickly because the delay for everyone to get on board very likely has not been in vain but in preparation. NWBO is talking like DCVax is for more than just brain tumors. Have regulators been saying the same thing?; ). Did regulators want the bigger boat because they could see where the demand would be coming from and didn’t want to get caught in the middle of a stampede?; ). I don’t think Dr. Linda Liau just skips town for no reason when something important is about to be shared. Best wishes.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
